Former imc2 Director to Foster New and Existing Partnerships
(PRWEB) April 21, 2010 -- HealthTalker, the leader in word of mouth (WOM) marketing campaigns for the pharmaceutical and biotechnology industry, announces the appointment of Collie Turner to HealthTalker’s Core Leadership Team as the Senior Director of Strategic Partnerships.
Turner will focus on driving new business and identifying untapped opportunities for HealthTalker’s pharmaceutical-focused WOM campaigns. HealthTalker’s programs mobilize a base of highly engaged patients and/or caregivers who participate in a multi-faceted offline and online experience.
“Our business continues to grow as we head into our fourth year and it’s great to see that more companies recognize the value our word of mouth marketing approach offers,” said Andy Levitt, Founder & CEO, HealthTalker. “Collie will enable us to accelerate the awareness of our company’s service offering and expand our business. The combination of Collie’s background, talent, and knowledge of the industry made her the ideal person for this position.”
With more than 13 years of experience, Turner has provided strategic guidance and account development for the world's largest pharmaceutical companies including Bristol Myers Squibb, EMD Serono, GlaxoSmithKline, Pfizer, Shire and Wyeth. Turner will be influential in strengthening HealthTalker’s existing client relationships while opening new doors for strategic partnerships.
Turner’s addition to the HealthTalker team signals the ongoing growth and development of the Company. HealthTalke
Copyright©2010 Vocus, Inc.
All rights reserved